



Disease in the 
Elderly, United 
States 
To the Editor: Zilberberg et al. (1) 
recently commented on the increase of 
hospitalizations for Clostridium dif-
fi cile–associated disease (CDAD) and 
noted an increase in the case-fatality 
rate during 2000–2005. These fi ndings 
refer to the entire US adult population 
and agree with our observations for 
the elderly (>65 years of age). We as-
sessed trends of CDAD in the elderly 
by using hospital billing data from the 
Centers for Medicare and Medicaid 
Services (CMS), which covers 98% 
of the elderly population (2). We ab-
stracted all 1,054,125 hospitalization 
records that included C. diffi cile (In-
ternational Classifi cation of Diseases, 
9th revision, Clinical Modifi cation 
[ICD 9-CM], diagnosis code 008.45) 
in any of the 10 diagnosis code po-
sitions for a 14-year period (1991–
2004). We used elderly-population 
data from the 1990 and 2000 US Cen-
sus. The ICD code for C. diffi cile was 
introduced in 1992. Case-patients in 
our dataset prior to this date represent 
severe illness and were hospitalized 
for >1 year and therefore were still in 
the hospital when the ICD code was 
introduced. We considered data from 
1993 through 2004 because 1991 and 
1992 are not representative due to in-
troduction of the ICD code.
We observed an increase in over-
all hospitalizations that included a di-
agnosis for CDAD (online Appendix 
Figure, panel A, available from www.
cdc.gov/EID/content/15/2/343-appF.
htm) and an increase in rates of CDAD 
from 13.71/10,000 elderly in 1993 to 
38.78/10,000 in 2004 (3). The highest 
rate of hospitalizations was detected in 
the oldest patients (>85 years of age), 
48.2/10,000 vs. 11.9 in those 65–74 
years of age and 26.0 in those 75–84 
years of age (3). These rates might be 
higher than rates reported by Zilber-
berg et al. because our records account 
for all treated conditions recorded by 
all 10 diagnosis codes. The ICD code 
for CDAD typically does not appear 
in the primary and secondary diagno-
sis; overall, 60% of all CMS records 
list CDAD as codes 3–10 (3). Primary 
and secondary codes typically repre-
sent diagnoses for which the patient 
is admitted, whereas diagnosis codes 
3–10 are codes used for chronic condi-
tions and sequelae. The online Appen-
dix Figure, panel A, shows the change 
in the proportion of CDAD cases in 
each diagnosis code over the study 
period. The proportion of CDAD in 
the primary and secondary diagnosis 
position increased during 1996–1997; 
however, this proportion is stabilizing 
at ≈25%.
Zilberberg et al. observed a dou-
bling in age-adjusted case-fatality 
rates from 1.2% in 2000 to 2.2% in 
2004 (1), which is an annual increase 
of 0.2% over the 5-year period. We are 
not able to calculate case-fatality rate 
by using CMS data because these data 
do not provide cause of death, only an 
indicator of whether the patient died 
during that hospital stay. However, we 
observed an increase in the percent-
age of patients with CDAD who died, 
from 8.8% in 1993 to 9.7% in 2004, 
which is an annual increase of 0.075% 
over the 12-year period. We also ob-
served a peak in 2000; 10.4% of pa-
tients with CDAD died. This peak is 
unusual and unexplained and requires 
further analysis. Data on deaths must 
be interpreted with caution because 
they may be affected by severe condi-
tions and age (oldest patients).
We observed an increasing trend 
and strong seasonal pattern in CDAD 
hospitalizations. The online Appendix 
Figure, panel B, shows this seasonal 
pattern by week during 1993–2004. 
This fi gure shows an increasing trend 
over time with a sharp change in slope 
in 2001. This increasing trend may 
represent an increase in disease or 
may be caused by increased testing 
and recognition of disease. Diagnosis 
of CDAD in the United States is now 
made by using an enzyme immunoas-
say that is relatively easier and cheaper 
to perform than a cytotoxin assay (4), 
which may account for the increased 
trend.
Increases in rates of CDAD may 
be caused by a reporting bias of gas-
troenteric diseases (5–7). To assess 
this possibility, we extracted all re-
cords that included other infectious 
gastroenteritis without CDAD (all 
other gastrointestinal [GI] infections, 
ICD 001–009 without 008.45) and 
compared the trend with CDAD hos-
pitalizations (online Appendix Figure, 
panel B). The online Appendix Figure 
shows that rates for all other GI infec-
tions remained fairly constant over the 
study period, and a reporting bias for 
GI infections does not account for the 
≈3-fold increase in CDAD hospital-
izations. CDAD hospitalization rates 
for the elderly also show a strong an-
nual seasonal pattern (online Appen-
dix Figure, panel B), which was esti-
mated to peak in the second week of 
March, the 10th week of the year. This 
seasonality suggests dominant routes 
of transmission that may be environ-
mentally driven.
Our fi ndings support the obser-
vations of Zilberberg et al. and dem-
onstrate the substantial increase in 
CDAD-related hospitalizations over 
time. These fi ndings and the aging 
population in the United States under-
score the need for further research to 
understand all aspects of CDAD.
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Viral Etiology of 
Common Cold in 
Children, Finland
To the Editor: The common cold 
is regarded as a viral disease. In the fi rst 
years of the 21st century, several new 
respiratory viruses have been identi-
fi ed, such as human metapneumovi-
rus (hMPV), coronaviruses NL63 and 
HKU1, and human bocavirus (HBoV). 
Many studies have addressed the role 
of these viruses in hospital settings, 
but few studies have been conducted 
among outpatients. We examined the 
etiology of the common cold in young 
children who were newly symptomat-
ic but had no need of hospital care. We 
hypothesized that the etiology could 
be detected in all cases by using mod-
ern diagnostics that test for 16 viruses 
in outpatients. 
Between February 1996 and April 
1998, we collected nasopharyngeal 
aspirate samples in an outpatient set-
ting from 194 Finnish children hav-
ing newly onset (<48 h) symptoms of 
common cold but no acute otitis media 
(AOM) or other symptoms demanding 
antimicrobial therapy (1). The mean 
age of the study population was 2.1 
years (range 0.7–3.9 years), and 81% 
attended day care. The parents of all 
participants gave written informed 
consent, and the study protocol was 
approved by the Ethics Committee of 
Turku University Hospital in Turku, 
Finland.
The nasopharyngeal aspirate 
samples were processed freshly for 
antigen detection (respiratory syncy-
tial virus [RSV]; parainfl uenza viruses 
1, 2, and 3; infl uenza A and B viruses; 
and adenovirus) by time-resolved fl u-
oroimmunoassay (2). Stored samples 
were subjected to nucleic acid test-
ing (NAT) for picornaviruses; RSV; 
coronaviruses 229E, OC43, NL63, 
and HKU1; infl uenza C virus; HBoV; 
hMPV; and adenovirus. Recently, 
these samples were reanalyzed for 
rhinovirus and enterovirus using real-
time PCR for the amplifi cation step 
(1,3–6).
At least 1 respiratory virus was 
detected in 179 (92%) of 194 children. 
Rhinovirus was the most common re-
spiratory virus, found in 138 (71%) 
children (Table). Other viruses were 
found in varying proportions: HBoV 
was present in 27 (14%) children; ade-
novirus was found in 23 (12%) (3 were 
positive by antigen detection, and 23 
by NAT); enterovirus was present in 
20 (10%); coronaviruses were found 
in 11 (6%) (NL63:7; HKU1:2; 229E/
OC43:2); infl uenza viruses were pres-
ent in 11 (6%) (A:4; B:1; C:6); RSV 
was shown in 8 (4%) (all were posi-
tive by antigen detection and NAT); 
parainfl uenza viruses were present 
in 7 (4%) (1:1; 3:6); and hMPV was 
found in 3 (2%). The Table shows the 
concomitant occurrence of all viruses. 
Among children with a positive viral 
fi nding, 46 (26%) had 2 viruses, and 
10 (6%) had 3 or 4 viruses concomi-
tantly. The viruses occurring most 
frequently with other viruses were ad-
enovirus (100%), HBoV (81%), and 
enterovirus (75%).
Although our diagnostic panel 
was incomplete, lacking parechovi-
ruses and parainfl uenza type 4 virus, 
we detected >1 respiratory viruses in 
92% of the children who had a com-
mon cold. As expected, rhinovirus 
was the leading cause of the common 
cold in these children. The role of pi-
cornaviruses was also emphasized by 
the abundance of enteroviruses. En-
terovirus has gained attention mainly 
in severe infections, e.g., meningo-
encephalitis, and is rarely included in 
diagnostics for respiratory infections. 
However, PCR has shown that en-
terovirus commonly causes upper and 
lower respiratory infections that may 
be complicated by AOM or expira-
tory wheezing (4,7). Thus, enterovirus 
should be included in the diagnostic 
panels of respiratory infections. HBoV 
was the second most prevalent virus in 
our study population. Since its discov-
ery in 2005, HBoV positivity has been 
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Letters commenting on recent articles 
as well as letters reporting cases, out-
breaks, or original research are wel-
come. Letters commenting on articles 
should contain no more than 300 
words and 5 references; they are more 
likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words 
and 10 references. They may have 1 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.
